Valsartan attenuates cardiac dysfunction and remodelling in patients with HCM
Sign Up to like & getrecommendations! Published in 2021 at "Nature Reviews Cardiology"
DOI: 10.1038/s41569-021-00636-y
Abstract: Valsartan is safe and effective in improving cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from the phase II VANISH trial. read more here.
Keywords: valsartan attenuates; patients hcm; remodelling patients; cardiac dysfunction ... See more keywords